000 | 01919 a2200577 4500 | ||
---|---|---|---|
005 | 20250517162918.0 | ||
264 | 0 | _c20170922 | |
008 | 201709s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0180995 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMagnes, Teresa | |
245 | 0 | 0 |
_aPrognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy. _h[electronic resource] |
260 |
_bPloS one _c2017 |
||
300 |
_ae0180995 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdiagnosis |
650 | 0 | 4 |
_aCetuximab _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHead and Neck Neoplasms _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLeukocyte Count |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSquamous Cell Carcinoma of Head and Neck |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aMelchardt, Thomas | |
700 | 1 | _aWeiss, Lukas | |
700 | 1 | _aMittermair, Christof | |
700 | 1 | _aNeureiter, Daniel | |
700 | 1 | _aKlieser, Eckhard | |
700 | 1 | _aGampenrieder, Simon | |
700 | 1 | _aMoser, Gerhard | |
700 | 1 | _aGaggl, Alexander | |
700 | 1 | _aGreil, Richard | |
700 | 1 | _aEgle, Alexander | |
773 | 0 |
_tPloS one _gvol. 12 _gno. 7 _gp. e0180995 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0180995 _zAvailable from publisher's website |
999 |
_c27347290 _d27347290 |